Literature DB >> 16477654

Mitochondrial dysfunction in Brooks-Wisniewski-Brown syndrome.

Eva Morava1, Richard Rodenburg, Frans Hol, Linda De Meirleir, Sara Seneca, Rebekka Busch, Lambert van den Heuvel, Jan Smeitink.   

Abstract

Brooks, Wisniewski, and Brown described a familial presentation of severe developmental retardation, speech delay, static encephalopathy with atrophic hydrocephalus, microcephaly, progressive spastic diplegia, a characteristic facial appearance, optic atrophy, and growth retardation associated with hypoplastic corpus callosum in one of the patients. The authors postulated a distinct X-linked mental retardation syndrome. Later on a similar phenotype was observed in three male siblings with an early lethal outcome. Here we describe three patients with several overlapping features and a progressive neurological picture presenting with a significantly compromised mitochondrial oxidative phosphorylation measured in a fresh muscle biopsy. Neurological deterioration is a commonly observed feature in mitochondrial disorders. Based on the unique combination of the clinical symptoms, we suggest that our patients have the Brooks-Wisniewski-Brown syndrome. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477654     DOI: 10.1002/ajmg.a.31117

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Mitochondrial dysfunction contributes to alveolar developmental arrest in hyperoxia-exposed mice.

Authors:  Veniamin Ratner; Anatoly Starkov; Dzmitry Matsiukevich; Richard A Polin; Vadim S Ten
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-23       Impact factor: 6.914

2.  A HS6ST2 gene variant associated with X-linked intellectual disability and severe myopia in two male twins.

Authors:  Leda Paganini; Loubna A Hadi; Massimiliano Chetta; Davide Rovina; Laura Fontana; Patrizia Colapietro; Eleonora Bonaparte; Lidia Pezzani; Paola Marchisio; Silvia M Tabano; Jole Costanza; Silvia M Sirchia; Laura Riboni; Donatella Milani; Monica Miozzo
Journal:  Clin Genet       Date:  2018-12-26       Impact factor: 4.438

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.